サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1489263

In-Silico創薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global In-Silico Drug Discovery Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.56円
In-Silico創薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年05月01日
発行: Value Market Research
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In-Silico創薬市場の世界需要は、2023年の30億9,970万米ドルから2032年には83億3,005万米ドル近くの市場規模に達すると推定され、調査期間2024年～2032年のCAGRは11.61%です。

In-Silico創薬では、コンピューター・シミュレーションや計算手法を利用して新薬を同定・開発します。このアプローチでは、バイオインフォマティクス、分子モデリング、データ解析を活用して、薬剤候補が生物学的標的とどのように相互作用するかを予測します。In-Silico技術は、膨大な化合物ライブラリーをスクリーニングし、潜在的な医薬品候補を同定し、リード化合物を最適化し、薬物動態学的・毒物学的プロファイルを予測することができます。この手法は創薬プロセスを大幅に加速し、コストを削減し、大規模な実験室作業の必要性を最小限に抑えます。

市場力学

In-Silico創薬市場は、より効率的で費用対効果が高く、迅速な創薬プロセスの必要性によって牽引されています。計算生物学とバイオインフォマティクスの進歩により、in-silico創薬の機能が大幅に強化され、研究者は薬物相互作用の予測、薬剤候補の最適化、潜在的な副作用の特定を開発の初期段階で行うことができるようになった。従来の医薬品開発のコストが上昇し、多因子疾患をターゲットとする複雑さが増しているため、In-Silicoアプローチはより魅力的なものとなっています。さらに、医薬品開発プロセスにおける計算手法の統合に対する規制当局のサポートが、より多くの製薬企業にこれらの技術の採用を促しています。高性能コンピューティング・リソースと洗練されたソフトウェア・ツールの利用可能性が高まっていることも、In-Silico創薬市場の成長をさらに後押ししています。しかし、計算の複雑さやデータの正確性に関する懸念が、今後数年間の市場成長の課題となる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、In-Silico創薬の世界市場における各セグメントを包括的に評価することもできます。In-Silico創薬産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおけるIn-Silico創薬市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 In-Silico創薬- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 In-Silico創薬の世界市場分析：製品別

  • 概要
  • 実績および予測データ分析
  • サービス型ソフトウェア
  • ソフトウェア
  • サービス型コンサルタント

第6章 In-Silico創薬の世界市場分析：ワークフロー別

  • 概要
  • 実績および予測データ分析
  • 前臨床試験
  • 探索
  • 臨床試験

第7章 世界のIn-Silico創薬市場分析：標的治療領域別

  • 概要
  • 実績および予測データ分析
  • 代謝疾患
  • HIV
  • 感染症
  • 筋骨格系疾患
  • 精神疾患
  • 神経疾患
  • 腫瘍性疾患

第8章 世界のin-silico創薬市場分析：エンドユーザー別

  • 概要
  • 実績および予測データ分析
  • 契約研究機関
  • 製薬・バイオ医薬品企業
  • 学術・研究機関

第9章 In-Silico創薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 In-Silico創薬企業の競合情勢

  • In-Silico創薬市場競争
  • 提携・共同研究・契約
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Charles River Laboratories
  • Curia Global Inc.
  • Certara USA
  • Creative Biostructure
  • Chemical Computing Group ULC
  • GenScript
  • Sygnature Discovery
  • Abzena Ltd.
  • BioNTech SE
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Software-as-a-Service Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Consultancy-as-a-Service Market Sales By Geography (USD MN)
  • Analysis By Workflow (USD MN)
  • Pre-Clinical Tests Market Sales By Geography (USD MN)
  • Discovery Market Sales By Geography (USD MN)
  • Clinical Tests Market Sales By Geography (USD MN)
  • Analysis By Target Therapeutic Area (USD MN)
  • Metabolic disorders Market Sales By Geography (USD MN)
  • HIV Market Sales By Geography (USD MN)
  • Infectious diseases Market Sales By Geography (USD MN)
  • Musculoskeletal disorders Market Sales By Geography (USD MN)
  • Mental disorders Market Sales By Geography (USD MN)
  • Neurological disorders Market Sales By Geography (USD MN)
  • Oncological disorders Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Pharmaceutical and Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic and Research Institutes Market Sales By Geography (USD MN)
  • Global In-Silico Drug Discovery Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In-Silico Drug Discovery Report
  • Market Research Process
  • Market Research Methodology
  • Global In-Silico Drug Discovery Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Target Therapeutic Area
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Software-as-a-Service Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Consultancy-as-a-Service Market Sales By Geography (USD MN)
  • Global Market Analysis By Workflow (USD MN)
  • Pre-Clinical Tests Market Sales By Geography (USD MN)
  • Discovery Market Sales By Geography (USD MN)
  • Clinical Tests Market Sales By Geography (USD MN)
  • Global Market Analysis By Target Therapeutic Area (USD MN)
  • Metabolic disorders Market Sales By Geography (USD MN)
  • HIV Market Sales By Geography (USD MN)
  • Infectious diseases Market Sales By Geography (USD MN)
  • Musculoskeletal disorders Market Sales By Geography (USD MN)
  • Mental disorders Market Sales By Geography (USD MN)
  • Neurological disorders Market Sales By Geography (USD MN)
  • Oncological disorders Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Contract Research Organizations Market Sales By Geography (USD MN)
  • Pharmaceutical and Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic and Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114720

The global demand for In-Silico Drug Discovery Market is presumed to reach the market size of nearly USD 8330.05 Million by 2032 from USD 3099.7 Million in 2023 with a CAGR of 11.61% under the study period 2024-2032.

In-silico drug discovery involves using computer simulations and computational methods to identify and develop new pharmaceuticals. This approach utilizes bioinformatics, molecular modeling, and data analysis to predict how drug candidates interact with biological targets. In-silico techniques can screen vast libraries of compounds, identify potential drug candidates, optimize lead compounds, and predict their pharmacokinetic and toxicological profiles. This method significantly accelerates the drug discovery process, reduces costs, and minimizes the need for extensive laboratory work.

MARKET DYNAMICS

The in-silico drug discovery market is driven by the need for more efficient, cost-effective, and faster drug discovery processes. Advances in computational biology and bioinformatics have significantly enhanced the capabilities of in-silico drug discovery, enabling researchers to predict drug interactions, optimize drug candidates, and identify potential side effects early in development. The rising cost of traditional drug development and the increasing complexity of targeting multifactorial diseases make In-Silico approaches more attractive. Additionally, regulatory support for integrating computational methods in drug development processes encourages more pharmaceutical companies to adopt these technologies. The growing availability of high-performance computing resources and sophisticated software tools further propels the growth of the in-silico drug discovery market. However, computational complexities and data accuracy concerns may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of In-Silico Drug Discovery. The growth and trends of In-Silico Drug Discovery industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the In-Silico Drug Discovery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Software-as-a-Service
  • Software
  • Consultancy-as-a-Service

By Workflow

  • Pre-Clinical Tests
  • Discovery
  • Clinical Tests

By Target Therapeutic Area

  • Metabolic disorders
  • HIV
  • Infectious diseases
  • Musculoskeletal disorders
  • Mental disorders
  • Neurological disorders
  • Oncological disorders

By End User

  • Contract Research Organizations
  • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In-Silico Drug Discovery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In-Silico Drug Discovery market include Charles River Laboratories, Curia Global Inc., Certara, USA, Chemical Computing Group ULC, GenScript, Sygnature Discovery, Abzena Ltd., BioNTech SE, Creative Biostructure. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. IN-SILICO DRUG DISCOVERY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Target Therapeutic Area
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Software-as-a-Service Historic and Forecast Sales By Regions
  • 5.4. Software Historic and Forecast Sales By Regions
  • 5.5. Consultancy-as-a-Service Historic and Forecast Sales By Regions

6. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY WORKFLOW

  • 6.1. Overview By Workflow
  • 6.2. Historical and Forecast Data Analysis By Workflow
  • 6.3. Pre-Clinical Tests Historic and Forecast Sales By Regions
  • 6.4. Discovery Historic and Forecast Sales By Regions
  • 6.5. Clinical Tests Historic and Forecast Sales By Regions

7. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY TARGET THERAPEUTIC AREA

  • 7.1. Overview By Target Therapeutic Area
  • 7.2. Historical and Forecast Data Analysis By Target Therapeutic Area
  • 7.3. Metabolic disorders Historic and Forecast Sales By Regions
  • 7.4. HIV Historic and Forecast Sales By Regions
  • 7.5. Infectious diseases Historic and Forecast Sales By Regions
  • 7.6. Musculoskeletal disorders Historic and Forecast Sales By Regions
  • 7.7. Mental disorders Historic and Forecast Sales By Regions
  • 7.8. Neurological disorders Historic and Forecast Sales By Regions
  • 7.9. Oncological disorders Historic and Forecast Sales By Regions

8. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Contract Research Organizations Historic and Forecast Sales By Regions
  • 8.4. Pharmaceutical and Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 8.5. Academic and Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL IN-SILICO DRUG DISCOVERY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN-SILICO DRUG DISCOVERY COMPANIES

  • 10.1. In-Silico Drug Discovery Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF IN-SILICO DRUG DISCOVERY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Charles River Laboratories
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Curia Global Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Certara USA
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Creative Biostructure
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Chemical Computing Group ULC
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. GenScript
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Sygnature Discovery
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Abzena Ltd.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. BioNTech SE
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies